How to read: Every bubble is one Indian tofacitinib exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Tofacitinib report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial tofacitinib trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian tofacitinib suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Tofacitinib India trade report
P
Product scope
Tofacitinib
All variants merged — branded and generic formulations of tofacitinib
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
155
Every commercial tofacitinib trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a mixed: Oct $719.5K, Nov $244.4K, Dec $97.6K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$719.5K
Oct USD
16 shipments
2
$244.4K
Nov USD
-66.0% MoM
3
$97.6K
Dec USD
-60.1% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 66.0% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $720K, making it the strongest month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: HEET HEALTHCARE PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import tofacitinib from India, how much they buy, and who supplies each market
KEY TAKEAWAYCanada absorbs 64.6% of India’s 2025-Q4 tofacitinib trade ($685.6K). Beyond the top 10 destinations, 31 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 10 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 31 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much tofacitinib India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$114K
10.8% of trade
10 countries · 82 shipments
Europe
$10K
0.9% of trade
2 countries · 6 shipments
Americas
$849K
79.9% of trade
10 countries · 33 shipments
Africa
$89K
8.4% of trade
10 countries · 34 shipments
Fig 4.1 Canada is the #1 corridor ($686K) — 30 flow arcs from India radiate across 4 continents.
How to read: The world map shows every country colored by how much Indian tofacitinib it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
Canada
$686K
2
SUN PHARMACEUTICAL INDUSTRIES LTD
$686K
—
—
—
—
2
Guatemala
$158K
5
CROIENT PHARMA PVT LTD
$148K
AZISTA INDUSTRIES PVT LTD
$10K
—
—
3
Iraq
$57K
19
HEET HEALTHCARE PVT LTD
$34K
VATS INDUSTRIES PVT LTD
$13K
ZEAL PHARMA
$10K
4
Kenya
$33K
12
4CARE LIFESCIENCE PVT LTD
$12K
MICRO LABS LTD
$11K
AJANTA PHARMA LTD
$10K
5
Zimbabwe
$25K
2
MICRO LABS LTD
$25K
—
—
—
—
6
United Arab Emirates
$23K
26
SMP LIFECARE
$11K
LILIUM INTERNATIONAL PVT LTD
$5K
BAKER & DAVIS PVT LTD
$5K
7
Afghanistan
$19K
4
MEDMATRIX ASSOCIATES
$12K
KWALITY PHARMACEUTICALS LTD
$7K
KERK
$537
8
Uganda
$13K
4
AJANTA PHARMA LTD
$13K
—
—
—
—
9
Turkey
$10K
8
LILIUM INTERNATIONAL PVT LTD
$5K
RMPL PHARMA LLP
$3K
HEET HEALTHCARE PVT LTD
$2K
10
Mauritius
$9K
6
MICRO LABS LTD
$5K
PLEASANT EXPORTS
$4K
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 10.8% of USD — but Canada is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
64.6%
#1 country share
Canada alone
90.2%
Top 5 share
5 of 32 countries
99.2%
Top 15 share
Long tail of 17 countries = 0.8%
HHI 4449
Destination HHI
Highly concentrated
32
Countries served
Global pharma reach from India
10
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
45 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYSUN PHARMACEUTICAL INDUSTRIES LTD ($685.6K, 64.6% share) and CROIENT PHARMA PVT LTD ($148.3K) together control 78.6% of India’s 2025-Q4 tofacitinib trade. The top 5 suppliers hold 89.7%. 45 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian tofacitinib suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 SUN PHARMACEUTICAL INDUSTRIES LTD leads by $537K over CROIENT PHARMA PVT LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: SUN PHARMACEUTICAL INDUSTRIES is #1 by value but #13 by volume.
Fig 5.2 AJANTA PHARMA LTD also leads by shipment count (10) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: SUN PHARMACEUTICAL INDUSTRIES moves from #13 by volume to #1 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 45 tofacitinib suppliers split into strategic segments
KEY TAKEAWAY12 suppliers (25%) generate 97.1% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 SUN PHARMACEUTICAL INDUSTRIES LTD and CROIENT PHARMA PVT LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 97.1% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
49 importers across 32 countries — who is buying Indian tofacitinib and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 85.7% of total USD. 90% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian tofacitinib. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 M/S.SUN PHARMA CANADA INC is the #1 importer at $686K (64.6%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian tofacitinib prices vary by supplier, country and dosage form
KEY TAKEAWAYTofacitinib prices span 14499× ($0.013 → $195.23). The coefficient of variation is 2.16. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. AJANTA PHARMA LTDSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. CROIENT PHARMA PVTSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. SMP LIFECARESourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. SUN PHARMACEUTICAL INDUSTRIESSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Oct 2025
SUN PHARMACEUTIC…
Canada
Tablet
350
$73K
$209.76
Specialty / small-batch
Nov 2025
3S CORP
Chile
Tablet
2
$390.47
$195.23
Specialty / small-batch
Oct 2025
SUN PHARMACEUTIC…
Canada
Tablet
6K
$612K
$101.63
Specialty / small-batch
Nov 2025
SARA TRADING CORP
British Virgin Islands
Tablet
20
$2K
$94.06
Specialty / small-batch
Oct 2025
MICRO LABS LTD
France
Tablet
100
$8K
$75.90
Specialty / small-batch
Nov 2025
R L PHARMA
Venezuela
Tablet
5
$176.37
$35.27
Specialty / small-batch
Nov 2025
R L PHARMA
Venezuela
Tablet
10
$352.73
$35.27
Specialty / small-batch
Dec 2025
VAMA LIFECARE PV…
Brazil
Tablet
2
$64.00
$32.00
Specialty / small-batch
Nov 2025
GAIA TRADE PVT LTD
United Arab Emirates
—
1
$26.80
$26.80
Specialty / small-batch
Nov 2025
GAIA TRADE PVT LTD
United Arab Emirates
Tablet
6
$160.71
$26.78
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
AASHIRWAD PHARMA…
Dominica
Tablet
30
$0.189
$0.0063
Bulk generic tablet
Dec 2025
AMARI TRADE ALLI…
Turkey
Tablet
600
$8.08
$0.013
Small sample / trial shipment
Dec 2025
M T MADON EXPORTS
Turkey
Tablet
30
$0.530
$0.018
Small sample / trial shipment
Nov 2025
KWALITY PHARMACE…
Afghanistan
Tablet
90K
$7K
$0.074
Dec 2025
NIVIRA EXPORTS
Chile
Tablet
1
$0.095
$0.095
Small sample / trial shipment
Dec 2025
DERRIC WOOD
United Arab Emirates
Tablet
4
$0.419
$0.105
Small sample / trial shipment
Dec 2025
RMPL PHARMA LLP
Lebanon
Tablet
100
$12.76
$0.128
Small sample / trial shipment
Oct 2025
MC PHARMA DISTRI…
Maldives
Tablet
180
$24.97
$0.139
Small sample / trial shipment
Nov 2025
MC PHARMA DISTRI…
Maldives
Tablet
364
$50.65
$0.139
Small sample / trial shipment
Nov 2025
MC PHARMA DISTRI…
Maldives
Tablet
364
$50.65
$0.139
Small sample / trial shipment
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship tofacitinib, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYTofacitinib leaves India through 9+ ports. The top 5 (DHANNAD ICD, MUMBAI AIR (SAHAR), AHMEDABAD AIR) handle 95.1% of total USD. ICD moves 4% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DHANNAD ICD handles $686K — top 9 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYICD dominates at 4% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
ICD
$709K
66.8% of USD · 3.9% of ships
AIR
$323K
30.4% of USD · 88.4% of ships
SEA
$30K
2.8% of USD · 7.7% of ships
Fig 8.3 The dominant corridor is DHANNAD ICD → Sea → N. America ($686K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYUganda is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 3309).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Uganda (HHI 10,000) is the most concentrated — Kenya (HHI 3,309) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
M/S.SUN PHARMA CANAD…
Canada
SUN PHARMACEUTIC…
$686K
2
CRITICAL
VMG HEALTHCARE PRODU…
Guatemala
CROIENT PHARMA P…
$74K
2
MEDIUM
ABACUS PHARMA (A) LTD
Uganda
AJANTA PHARMA LTD
$13K
4
MEDIUM
ZORWAY INTERNATIONAL…
Zimbabwe
MICRO LABS LTD
$12K
1
MEDIUM
GULF IMPEX FZC
Afghanistan
MEDMATRIX ASSOCI…
$12K
2
MEDIUM
OMILIFE LTD
Kenya
4CARE LIFESCIENC…
$12K
3
MEDIUM
EPHESUS GENERAL TRAD…
United Arab Emirates
SMP LIFECARE
$11K
2
MEDIUM
LABOREX KENYA LTD
Kenya
MICRO LABS LTD
$11K
1
MEDIUM
Conclusion: 44 buyers depend on exactly one Indian supplier, representing $904K in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
Canada
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Guatemala
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Iraq
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Kenya
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Zimbabwe
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
United Arab Emirates
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Afghanistan
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Uganda
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Turkey
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Mauritius
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
France
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Madagascar
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Tanzania
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Poland
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Laos
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 11 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in Canada
This Q
HIGH
A2
Offer alternative to top multi-source buyer
This Q
HIGH
A3
Audit Uganda lock-ins (HHI 10000)
This Q
MED
A5
Enter Canada (1 suppliers)
This Q
HIGH
A6
Enter Guatemala (2 suppliers)
This Q
MED
A8
Build Guatemala distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for Canada tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Canada
Other
1
$686K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
2
Guatemala
Other
2
$158K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
3
Kenya
Africa
5
$33K
+287%
LOW
Growing 287% with only 5 competitors
4
Iraq
Other
4
$57K
+105.3%
LOW
Growing 105% with only 4 competitors
5
Zimbabwe
Africa
1
$25K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Afghanistan
Asia
3
$19K
0%
LOW
Low competition (3 suppliers), accessible market
7
Uganda
Africa
1
$13K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
8
Turkey
Other
5
$10K
0%
LOW
Low competition (5 suppliers), accessible market
9
Mauritius
Africa
2
$9K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
10
France
Other
1
$8K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Madagascar
Africa
1
$6K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Guyana
Other
1
$1K
+130%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Tanzania
Africa
1
$3K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Poland
Other
2
$2K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
15
Laos
Asia
1
$2K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 155 2025-Q4 Tofacitinib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/tofacitinib
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 155 2025-Q4 tofacitinib shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian tofacitinib shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
155
across all regions
TOTAL USD
$1.06M
2025-Q4 FOB value
UNITS
177.5K
tablets, capsules, etc.
SUPPLIERS
45
Indian exporters
BUYERS
49
global importers
COUNTRIES
32
destinations
§10.2 Regional breakdown
Africa
$89K
8.4%
10 ctry · 34 ships
Asia
$114K
10.8%
10 ctry · 82 ships
Europe
$10K
0.9%
2 ctry · 6 ships
Americas
$849K
79.9%
10 ctry · 33 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $89K (8.4%), spanning 10 countries.
🏢
45 Indian suppliers shipped to 49 buyers across 32 countries — average shipment value $7K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 47 global tofacitinib importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian tofacitinib in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
M/S.SUN PHARMA CANADA INC
Canada
2
$686K
SUN PHARMACEUTICAL I…
Tablet
2
VMG HEALTHCARE PRODUCTS GUATEMALA S
Guatemala
2
$74K
CROIENT PHARMA PVT LTD
Tablet
3
ABACUS PHARMA (A) LTD
Uganda
4
$13K
AJANTA PHARMA LTD
Tablet
4
ZORWAY INTERNATIONAL PVT LTD
Zimbabwe
1
$12K
MICRO LABS LTD
Tablet
5
GULF IMPEX FZC
Afghanistan
2
$12K
MEDMATRIX ASSOCIATES
Tablet
6
OMILIFE LTD
Kenya
3
$12K
4CARE LIFESCIENCE PV…
Tablet
7
EPHESUS GENERAL TRADING FZE
United Arab Emirates
2
$11K
SMP LIFECARE
Tablet
8
LABOREX KENYA LTD
Kenya
1
$11K
MICRO LABS LTD
Tablet
9
HARLEYS LTD
Kenya
4
$10K
AJANTA PHARMA LTD
Tablet
10
GETICS S.A
Guatemala
1
$10K
AZISTA INDUSTRIES PV…
Tablet
11
ATLAS TRADING COMPANY
Iraq
3
$8K
HEET HEALTHCARE PVT …
Tablet, Ointment
12
E.P.DIS
France
1
$8K
MICRO LABS LTD
Tablet
13
TRUST ANESTHETIC LTD
Afghanistan
1
$7K
KWALITY PHARMACEUTIC…
Tablet
14
VIP SHIPPING LLC
United Arab Emirates
2
$5K
LILIUM INTERNATIONAL…
Tablet
15
IMOCO EXPRESS SERVICE
Turkey
2
$5K
LILIUM INTERNATIONAL…
Tablet
16
ZAPATERO INTERNATIONAL LTD
Mauritius
4
$4K
PLEASANT EXPORTS
Tablet
17
LABOREX MADAGASCAR
Madagascar
1
$3K
MICRO LABS LTD
Tablet
18
ARROW TRADING FZE
United Arab Emirates
4
$3K
BAKER & DAVIS PVT LTD
Tablet
19
ASTRA PHARMA (T) LTD
Tanzania
2
$3K
AJANTA PHARMA LTD
Tablet
20
OFFICE PHARMACEUTIQUE MALGACHE S.A
Madagascar
1
$3K
MICRO LABS LTD
Tablet
21
IBL LTD
Mauritius
1
$3K
MICRO LABS LTD
Tablet
22
FTM (MAURITIUS) LTD
Mauritius
1
$3K
MICRO LABS LTD
Tablet
23
LANA GRUP ITHALAT IHRACAT TICARET
Turkey
1
$2K
HEET HEALTHCARE PVT …
Other
24
VANTERPOOL ENTERPRISES LTD
British Virgin Islands
1
$2K
SARA TRADING CORP
Tablet
25
ZMC EXPRESS CARGO FZCO
United Arab Emirates
2
$868.37
SEATRACK INTERNATION…
Tablet
26
ETEMAD MOSLEH LTD
Afghanistan
1
$536.78
KERK
Tablet
27
JUAN PINTO
Venezuela
2
$529.10
R L PHARMA
Tablet
28
ALFRED BARBIERI
Venezuela
1
$500.05
R L PHARMA
Tablet
29
FOR THE ORDER OF
Chile
4
$436.22
3S CORP
Tablet
30
DR BALWANT SINGHS HOSPITAL INC
Guyana
1
$394.86
SOINS IMPEX
Tablet
31
STATE TRADING ORGANIZATION PLC
Maldives
6
$388.11
MC PHARMA DISTRIBUTORS
Tablet
32
IP GT
Kazakhstan
3
$382.58
SACRED LEAVES PVT LTD
Tablet
33
EMIRATES POST COMPANY
United Arab Emirates
9
$331.03
GAIA TRADE PVT LTD
Tablet
34
FARMACIA ETICA SPA
Chile
7
$233.40
NIVIRA EXPORTS
Tablet
35
SALAMA PHARMACUTICALS LTD
Kenya
3
$214.42
M T MADON EXPORTS
Tablet
36
TREE TOP HEALTH PVT LTD
Maldives
6
$143.87
MC PHARMA DISTRIBUTORS
Tablet
37
TO THE
Brazil
1
$64.00
VAMA LIFECARE PVT LTD
Tablet
38
JOEL ECKERT
Georgia
1
$61.10
NBG CORP
Tablet
39
EMIRATES POST GROUP
United Arab Emirates
2
$42.89
PREMIER ENTERPRISE
Ointment
40
TO THE, IMPORTING DEPARTMENT
Chile
4
$39.15
JPC GLOBAL
Tablet
41
AL-NOOR FOR DRUGS & MEDICAL APPLIAN
Egypt
2
$16.93
J.A. UNITED EXPORTS …
Tablet
42
THE PHARMACIST
Cayman Islands
1
$14.02
KALINDI OVERSEAS
Tablet
43
ABU ABDU
Turkey
1
$8.08
AMARI TRADE ALLIANCE…
Tablet
44
THE PURCHASE DEPARTMENT LLC
Chile
1
$1.06
KALINDI OVERSEAS
Tablet
45
BMS TIBBI MALZEMELER VE ILAC ITHALA
Turkey
1
$0.530
M T MADON EXPORTS
Tablet
46
FIRST CHOICE PHARMACY
Dominica
1
$0.189
AASHIRWAD PHARMA INT…
Tablet
47
KHAMPARN VANGXAIHOUA
Laos
1
$0.0000
ASPIDA LIFE SCIENCES…
Tablet
This report covers 155 2025-Q4 Tofacitinib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/tofacitinib
Talk to our trade analyst
Need a custom tofacitinib report or a deeper dive into any market? Our team is ready.